BioCorRx Inc. (OTCMKTS:BICX) Short Interest Update

BioCorRx Inc. (OTCMKTS:BICX) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 800 shares, a growth of 100.0% from the March 31st total of 400 shares. Based on an average daily trading volume, of 2,800 shares, the short-interest ratio is presently 0.3 days.

BioCorRx Trading Down 8.5 %

BioCorRx stock traded down $0.07 during midday trading on Friday, reaching $0.75. 902 shares of the company were exchanged, compared to its average volume of 1,508. The firm’s 50-day simple moving average is $1.02 and its 200-day simple moving average is $1.07. BioCorRx has a 1 year low of $0.67 and a 1 year high of $2.22.

BioCorRx (OTCMKTS:BICX) last issued its quarterly earnings results on Monday, April 1st. The company reported ($0.11) EPS for the quarter. The firm had revenue of $0.02 million for the quarter.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.